T17 cell immune polarization was discovered in patients with PAH, while intravascular triggers in CTEPH patients may stimulate CXCL9 to recruit cytotoxic lymphocytes, natural killer cells, and macrophages. This evidence concerns the gene CXCL9 and pulmonary arterial hypertension.